Oral Contrast Agent-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Oral Contrast Agent-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Oral Contrast Agent industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Oral Contrast Agent 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Oral Contrast Agent worldwide and market share by regions, with company and product introduction, position in the Oral Contrast Agent market
Market status and development trend of Oral Contrast Agent by types and applications
Cost and profit status of Oral Contrast Agent, and marketing status
Market growth drivers and challenges
The report segments the global Oral Contrast Agent market as:
Global Oral Contrast Agent Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Oral Contrast Agent Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Global Oral Contrast Agent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Global Oral Contrast Agent Market: Manufacturers Segment Analysis (Company and Product introduction, Oral Contrast Agent Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Contrast Agent-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Oral Contrast Agent industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Oral Contrast Agent 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Oral Contrast Agent worldwide and market share by regions, with company and product introduction, position in the Oral Contrast Agent market
Market status and development trend of Oral Contrast Agent by types and applications
Cost and profit status of Oral Contrast Agent, and marketing status
Market growth drivers and challenges
The report segments the global Oral Contrast Agent market as:
Global Oral Contrast Agent Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Oral Contrast Agent Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Global Oral Contrast Agent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Global Oral Contrast Agent Market: Manufacturers Segment Analysis (Company and Product introduction, Oral Contrast Agent Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL CONTRAST AGENT
1.1 Definition of Oral Contrast Agent in This Report
1.2 Commercial Types of Oral Contrast Agent
1.2.1 Barium-based Contrast Media
1.2.2 Iodinated Contrast Media
1.2.3 Gadolinium-based Contrast Media
1.2.4 Microbubble Contrast Media
1.3 Downstream Application of Oral Contrast Agent
1.3.1 Cardiovascular Disorders
1.3.2 Cancer
1.3.3 Gastrointestinal Disorders
1.3.4 Musculoskeletal Disorders
1.3.5 Neurological Disorders
1.3.6 Nephrological Disorders
1.4 Development History of Oral Contrast Agent
1.5 Market Status and Trend of Oral Contrast Agent 2013-2023
1.5.1 Global Oral Contrast Agent Market Status and Trend 2013-2023
1.5.2 Regional Oral Contrast Agent Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Oral Contrast Agent 2013-2017
2.2 Sales Market of Oral Contrast Agent by Regions
2.2.1 Sales Volume of Oral Contrast Agent by Regions
2.2.2 Sales Value of Oral Contrast Agent by Regions
2.3 Production Market of Oral Contrast Agent by Regions
2.4 Global Market Forecast of Oral Contrast Agent 2018-2023
2.4.1 Global Market Forecast of Oral Contrast Agent 2018-2023
2.4.2 Market Forecast of Oral Contrast Agent by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Oral Contrast Agent by Types
3.2 Sales Value of Oral Contrast Agent by Types
3.3 Market Forecast of Oral Contrast Agent by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Oral Contrast Agent by Downstream Industry
4.2 Global Market Forecast of Oral Contrast Agent by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Oral Contrast Agent Market Status by Countries
5.1.1 North America Oral Contrast Agent Sales by Countries (2013-2017)
5.1.2 North America Oral Contrast Agent Revenue by Countries (2013-2017)
5.1.3 United States Oral Contrast Agent Market Status (2013-2017)
5.1.4 Canada Oral Contrast Agent Market Status (2013-2017)
5.1.5 Mexico Oral Contrast Agent Market Status (2013-2017)
5.2 North America Oral Contrast Agent Market Status by Manufacturers
5.3 North America Oral Contrast Agent Market Status by Type (2013-2017)
5.3.1 North America Oral Contrast Agent Sales by Type (2013-2017)
5.3.2 North America Oral Contrast Agent Revenue by Type (2013-2017)
5.4 North America Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Oral Contrast Agent Market Status by Countries
6.1.1 Europe Oral Contrast Agent Sales by Countries (2013-2017)
6.1.2 Europe Oral Contrast Agent Revenue by Countries (2013-2017)
6.1.3 Germany Oral Contrast Agent Market Status (2013-2017)
6.1.4 UK Oral Contrast Agent Market Status (2013-2017)
6.1.5 France Oral Contrast Agent Market Status (2013-2017)
6.1.6 Italy Oral Contrast Agent Market Status (2013-2017)
6.1.7 Russia Oral Contrast Agent Market Status (2013-2017)
6.1.8 Spain Oral Contrast Agent Market Status (2013-2017)
6.1.9 Benelux Oral Contrast Agent Market Status (2013-2017)
6.2 Europe Oral Contrast Agent Market Status by Manufacturers
6.3 Europe Oral Contrast Agent Market Status by Type (2013-2017)
6.3.1 Europe Oral Contrast Agent Sales by Type (2013-2017)
6.3.2 Europe Oral Contrast Agent Revenue by Type (2013-2017)
6.4 Europe Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Oral Contrast Agent Market Status by Countries
7.1.1 Asia Pacific Oral Contrast Agent Sales by Countries (2013-2017)
7.1.2 Asia Pacific Oral Contrast Agent Revenue by Countries (2013-2017)
7.1.3 China Oral Contrast Agent Market Status (2013-2017)
7.1.4 Japan Oral Contrast Agent Market Status (2013-2017)
7.1.5 India Oral Contrast Agent Market Status (2013-2017)
7.1.6 Southeast Asia Oral Contrast Agent Market Status (2013-2017)
7.1.7 Australia Oral Contrast Agent Market Status (2013-2017)
7.2 Asia Pacific Oral Contrast Agent Market Status by Manufacturers
7.3 Asia Pacific Oral Contrast Agent Market Status by Type (2013-2017)
7.3.1 Asia Pacific Oral Contrast Agent Sales by Type (2013-2017)
7.3.2 Asia Pacific Oral Contrast Agent Revenue by Type (2013-2017)
7.4 Asia Pacific Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Oral Contrast Agent Market Status by Countries
8.1.1 Latin America Oral Contrast Agent Sales by Countries (2013-2017)
8.1.2 Latin America Oral Contrast Agent Revenue by Countries (2013-2017)
8.1.3 Brazil Oral Contrast Agent Market Status (2013-2017)
8.1.4 Argentina Oral Contrast Agent Market Status (2013-2017)
8.1.5 Colombia Oral Contrast Agent Market Status (2013-2017)
8.2 Latin America Oral Contrast Agent Market Status by Manufacturers
8.3 Latin America Oral Contrast Agent Market Status by Type (2013-2017)
8.3.1 Latin America Oral Contrast Agent Sales by Type (2013-2017)
8.3.2 Latin America Oral Contrast Agent Revenue by Type (2013-2017)
8.4 Latin America Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Oral Contrast Agent Market Status by Countries
9.1.1 Middle East and Africa Oral Contrast Agent Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Oral Contrast Agent Revenue by Countries (2013-2017)
9.1.3 Middle East Oral Contrast Agent Market Status (2013-2017)
9.1.4 Africa Oral Contrast Agent Market Status (2013-2017)
9.2 Middle East and Africa Oral Contrast Agent Market Status by Manufacturers
9.3 Middle East and Africa Oral Contrast Agent Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Oral Contrast Agent Sales by Type (2013-2017)
9.3.2 Middle East and Africa Oral Contrast Agent Revenue by Type (2013-2017)
9.4 Middle East and Africa Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRAST AGENT
10.1 Global Economy Situation and Trend Overview
10.2 Oral Contrast Agent Downstream Industry Situation and Trend Overview
CHAPTER 11 ORAL CONTRAST AGENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Oral Contrast Agent by Major Manufacturers
11.2 Production Value of Oral Contrast Agent by Major Manufacturers
11.3 Basic Information of Oral Contrast Agent by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Oral Contrast Agent Major Manufacturer
11.3.2 Employees and Revenue Level of Oral Contrast Agent Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ORAL CONTRAST AGENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 GE Healthcare (US)
12.1.1 Company profile
12.1.2 Representative Oral Contrast Agent Product
12.1.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of GE Healthcare (US)
12.2 Bracco Imaging (Italy)
12.2.1 Company profile
12.2.2 Representative Oral Contrast Agent Product
12.2.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bracco Imaging (Italy)
12.3 Bayer HealthCare (Germany)
12.3.1 Company profile
12.3.2 Representative Oral Contrast Agent Product
12.3.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bayer HealthCare (Germany)
12.4 Guerbet (France)
12.4.1 Company profile
12.4.2 Representative Oral Contrast Agent Product
12.4.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Guerbet (France)
12.5 Lantheus (US)
12.5.1 Company profile
12.5.2 Representative Oral Contrast Agent Product
12.5.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Lantheus (US)
12.6 Daiichi Sankyo (Japan)
12.6.1 Company profile
12.6.2 Representative Oral Contrast Agent Product
12.6.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Daiichi Sankyo (Japan)
12.7 Unijules Life Sciences (India)
12.7.1 Company profile
12.7.2 Representative Oral Contrast Agent Product
12.7.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Unijules Life Sciences (India)
12.8 J.B. Chemicals and Pharmaceuticals (India)
12.8.1 Company profile
12.8.2 Representative Oral Contrast Agent Product
12.8.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of J.B. Chemicals and Pharmaceuticals (India)
12.9 Spago Nanomedicine (Sweden)
12.9.1 Company profile
12.9.2 Representative Oral Contrast Agent Product
12.9.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Spago Nanomedicine (Sweden)
12.10 Taejoon Pharm (South Korea)
12.10.1 Company profile
12.10.2 Representative Oral Contrast Agent Product
12.10.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Taejoon Pharm (South Korea)
12.11 Jodas (India)
12.11.1 Company profile
12.11.2 Representative Oral Contrast Agent Product
12.11.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Jodas (India)
12.12 Magnus Health (India)
12.12.1 Company profile
12.12.2 Representative Oral Contrast Agent Product
12.12.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Magnus Health (India)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRAST AGENT
13.1 Industry Chain of Oral Contrast Agent
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRAST AGENT
14.1 Cost Structure Analysis of Oral Contrast Agent
14.2 Raw Materials Cost Analysis of Oral Contrast Agent
14.3 Labor Cost Analysis of Oral Contrast Agent
14.4 Manufacturing Expenses Analysis of Oral Contrast Agent
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Oral Contrast Agent in This Report
1.2 Commercial Types of Oral Contrast Agent
1.2.1 Barium-based Contrast Media
1.2.2 Iodinated Contrast Media
1.2.3 Gadolinium-based Contrast Media
1.2.4 Microbubble Contrast Media
1.3 Downstream Application of Oral Contrast Agent
1.3.1 Cardiovascular Disorders
1.3.2 Cancer
1.3.3 Gastrointestinal Disorders
1.3.4 Musculoskeletal Disorders
1.3.5 Neurological Disorders
1.3.6 Nephrological Disorders
1.4 Development History of Oral Contrast Agent
1.5 Market Status and Trend of Oral Contrast Agent 2013-2023
1.5.1 Global Oral Contrast Agent Market Status and Trend 2013-2023
1.5.2 Regional Oral Contrast Agent Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Oral Contrast Agent 2013-2017
2.2 Sales Market of Oral Contrast Agent by Regions
2.2.1 Sales Volume of Oral Contrast Agent by Regions
2.2.2 Sales Value of Oral Contrast Agent by Regions
2.3 Production Market of Oral Contrast Agent by Regions
2.4 Global Market Forecast of Oral Contrast Agent 2018-2023
2.4.1 Global Market Forecast of Oral Contrast Agent 2018-2023
2.4.2 Market Forecast of Oral Contrast Agent by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Oral Contrast Agent by Types
3.2 Sales Value of Oral Contrast Agent by Types
3.3 Market Forecast of Oral Contrast Agent by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Oral Contrast Agent by Downstream Industry
4.2 Global Market Forecast of Oral Contrast Agent by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Oral Contrast Agent Market Status by Countries
5.1.1 North America Oral Contrast Agent Sales by Countries (2013-2017)
5.1.2 North America Oral Contrast Agent Revenue by Countries (2013-2017)
5.1.3 United States Oral Contrast Agent Market Status (2013-2017)
5.1.4 Canada Oral Contrast Agent Market Status (2013-2017)
5.1.5 Mexico Oral Contrast Agent Market Status (2013-2017)
5.2 North America Oral Contrast Agent Market Status by Manufacturers
5.3 North America Oral Contrast Agent Market Status by Type (2013-2017)
5.3.1 North America Oral Contrast Agent Sales by Type (2013-2017)
5.3.2 North America Oral Contrast Agent Revenue by Type (2013-2017)
5.4 North America Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Oral Contrast Agent Market Status by Countries
6.1.1 Europe Oral Contrast Agent Sales by Countries (2013-2017)
6.1.2 Europe Oral Contrast Agent Revenue by Countries (2013-2017)
6.1.3 Germany Oral Contrast Agent Market Status (2013-2017)
6.1.4 UK Oral Contrast Agent Market Status (2013-2017)
6.1.5 France Oral Contrast Agent Market Status (2013-2017)
6.1.6 Italy Oral Contrast Agent Market Status (2013-2017)
6.1.7 Russia Oral Contrast Agent Market Status (2013-2017)
6.1.8 Spain Oral Contrast Agent Market Status (2013-2017)
6.1.9 Benelux Oral Contrast Agent Market Status (2013-2017)
6.2 Europe Oral Contrast Agent Market Status by Manufacturers
6.3 Europe Oral Contrast Agent Market Status by Type (2013-2017)
6.3.1 Europe Oral Contrast Agent Sales by Type (2013-2017)
6.3.2 Europe Oral Contrast Agent Revenue by Type (2013-2017)
6.4 Europe Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Oral Contrast Agent Market Status by Countries
7.1.1 Asia Pacific Oral Contrast Agent Sales by Countries (2013-2017)
7.1.2 Asia Pacific Oral Contrast Agent Revenue by Countries (2013-2017)
7.1.3 China Oral Contrast Agent Market Status (2013-2017)
7.1.4 Japan Oral Contrast Agent Market Status (2013-2017)
7.1.5 India Oral Contrast Agent Market Status (2013-2017)
7.1.6 Southeast Asia Oral Contrast Agent Market Status (2013-2017)
7.1.7 Australia Oral Contrast Agent Market Status (2013-2017)
7.2 Asia Pacific Oral Contrast Agent Market Status by Manufacturers
7.3 Asia Pacific Oral Contrast Agent Market Status by Type (2013-2017)
7.3.1 Asia Pacific Oral Contrast Agent Sales by Type (2013-2017)
7.3.2 Asia Pacific Oral Contrast Agent Revenue by Type (2013-2017)
7.4 Asia Pacific Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Oral Contrast Agent Market Status by Countries
8.1.1 Latin America Oral Contrast Agent Sales by Countries (2013-2017)
8.1.2 Latin America Oral Contrast Agent Revenue by Countries (2013-2017)
8.1.3 Brazil Oral Contrast Agent Market Status (2013-2017)
8.1.4 Argentina Oral Contrast Agent Market Status (2013-2017)
8.1.5 Colombia Oral Contrast Agent Market Status (2013-2017)
8.2 Latin America Oral Contrast Agent Market Status by Manufacturers
8.3 Latin America Oral Contrast Agent Market Status by Type (2013-2017)
8.3.1 Latin America Oral Contrast Agent Sales by Type (2013-2017)
8.3.2 Latin America Oral Contrast Agent Revenue by Type (2013-2017)
8.4 Latin America Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Oral Contrast Agent Market Status by Countries
9.1.1 Middle East and Africa Oral Contrast Agent Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Oral Contrast Agent Revenue by Countries (2013-2017)
9.1.3 Middle East Oral Contrast Agent Market Status (2013-2017)
9.1.4 Africa Oral Contrast Agent Market Status (2013-2017)
9.2 Middle East and Africa Oral Contrast Agent Market Status by Manufacturers
9.3 Middle East and Africa Oral Contrast Agent Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Oral Contrast Agent Sales by Type (2013-2017)
9.3.2 Middle East and Africa Oral Contrast Agent Revenue by Type (2013-2017)
9.4 Middle East and Africa Oral Contrast Agent Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRAST AGENT
10.1 Global Economy Situation and Trend Overview
10.2 Oral Contrast Agent Downstream Industry Situation and Trend Overview
CHAPTER 11 ORAL CONTRAST AGENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Oral Contrast Agent by Major Manufacturers
11.2 Production Value of Oral Contrast Agent by Major Manufacturers
11.3 Basic Information of Oral Contrast Agent by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Oral Contrast Agent Major Manufacturer
11.3.2 Employees and Revenue Level of Oral Contrast Agent Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ORAL CONTRAST AGENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 GE Healthcare (US)
12.1.1 Company profile
12.1.2 Representative Oral Contrast Agent Product
12.1.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of GE Healthcare (US)
12.2 Bracco Imaging (Italy)
12.2.1 Company profile
12.2.2 Representative Oral Contrast Agent Product
12.2.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bracco Imaging (Italy)
12.3 Bayer HealthCare (Germany)
12.3.1 Company profile
12.3.2 Representative Oral Contrast Agent Product
12.3.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Bayer HealthCare (Germany)
12.4 Guerbet (France)
12.4.1 Company profile
12.4.2 Representative Oral Contrast Agent Product
12.4.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Guerbet (France)
12.5 Lantheus (US)
12.5.1 Company profile
12.5.2 Representative Oral Contrast Agent Product
12.5.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Lantheus (US)
12.6 Daiichi Sankyo (Japan)
12.6.1 Company profile
12.6.2 Representative Oral Contrast Agent Product
12.6.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Daiichi Sankyo (Japan)
12.7 Unijules Life Sciences (India)
12.7.1 Company profile
12.7.2 Representative Oral Contrast Agent Product
12.7.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Unijules Life Sciences (India)
12.8 J.B. Chemicals and Pharmaceuticals (India)
12.8.1 Company profile
12.8.2 Representative Oral Contrast Agent Product
12.8.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of J.B. Chemicals and Pharmaceuticals (India)
12.9 Spago Nanomedicine (Sweden)
12.9.1 Company profile
12.9.2 Representative Oral Contrast Agent Product
12.9.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Spago Nanomedicine (Sweden)
12.10 Taejoon Pharm (South Korea)
12.10.1 Company profile
12.10.2 Representative Oral Contrast Agent Product
12.10.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Taejoon Pharm (South Korea)
12.11 Jodas (India)
12.11.1 Company profile
12.11.2 Representative Oral Contrast Agent Product
12.11.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Jodas (India)
12.12 Magnus Health (India)
12.12.1 Company profile
12.12.2 Representative Oral Contrast Agent Product
12.12.3 Oral Contrast Agent Sales, Revenue, Price and Gross Margin of Magnus Health (India)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRAST AGENT
13.1 Industry Chain of Oral Contrast Agent
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRAST AGENT
14.1 Cost Structure Analysis of Oral Contrast Agent
14.2 Raw Materials Cost Analysis of Oral Contrast Agent
14.3 Labor Cost Analysis of Oral Contrast Agent
14.4 Manufacturing Expenses Analysis of Oral Contrast Agent
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
